Led by Kanion-Yangtze River Delta TCM Green Intelligent Manufacturing Technology Innovation Consortium Formally Established

Big News! Results of a randomised, open, multicentre clinical study of the efficacy and safety of San Han Hua Shi Granules versus Nematrevir Tablets/Ritonavir Tablets Controlled for the Treatment of Novel Coronavirus Infections in Adults are released

Discussion on Government Work Report | Representative Xiao Wei: Continuously Leading Development with Innovation

Kanion Pharmaceutical, a National Technology Innovation Demonstration Enterprise, Re-passed the 2023 Review

Kanion Pharmaceutical Wins the Titles of "Top 100 Chinese Pharmaceutical Innovation Enterprises" and "Top 10 Most Investment-worthy Chinese Pharmaceutical Listed Enterprises", and Is Recognized as a "Best Practice Case in the Inheritance and Innovation of Traditional Chinese Medicine"

Guizhi Fuling Capsule has completed the IIb phase of clinical trials in the United states In 2015

Kanion Ranked 11th in the top 100 list of Chinese traditional medicine enterprises

In December 2020，The overseas online B2B platform was successfully built by Overseas business department

In 2019，Kanion built the industry's first Chinese medicine intelligent manufacturing factory